Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- M14-033 NCT02065622
- M14-064 NCT03368859
- M14-115 NCT02065570
- M14-171 NCT02384538
- M14-172 NCT02642432
- M14-173 NCT02601885
- M14-197 NCT02349451
- M14-217 NCT02305758
- M14-222 NCT02167945
- M14-224 NCT02292719
- M14-234 NCT02819635
- M14-234 No ClinicalTrials.gov identifier reported
- M14-237 NCT02099058
- M14-237 - A Study Evaluating the Safety Pharmacokinetics (PK) and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors No ClinicalTrials.gov identifier reported
- M14-239 NCT03539536
- M14-239 - Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer No ClinicalTrials.gov identifier reported
- M14-243 NCT02476617
- M14-327 NCT02782663
- M14-327 - A Study to Evaluate the Long-Term Efficacy Safety and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn Disease No ClinicalTrials.gov identifier reported
- M14-347 NCT02185014
- M14-358 NCT02203773
- M14-359 NCT02264990
- M14-360 NCT02412371
- M14-361 NCT02289690
- M14-387 NCT02287233
- M14-397 No ClinicalTrials.gov identifier reported
- M14-397 NCT03737812
- M14-398 & M14-397 No ClinicalTrials.gov identifier reported
- M14-423 NCT02219490
- M14-429 NCT02365662
- M14-430 NCT03345823
- M14-430 - A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn Disease Who Completed the Studies M14-431 or M14-433 No ClinicalTrials.gov identifier reported
- M14-431 NCT02819635
- M14-431 NCT03345823
- M14-433 NCT03345823
- M14-465 NCT02629159
- M14-465 - A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate No ClinicalTrials.gov identifier reported
- M14-467 NCT02462525
- M14-483 NCT02343406
- M14-496 NCT02814175
- M14-500 NCT02198651
- M14-533 NCT03006068
- M14-533 - A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) No ClinicalTrials.gov identifier reported
- M14-546 NCT02391480
- M14-658 - Study to Assess Adverse Events Change in Disease Activity and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis No ClinicalTrials.gov identifier reported
- M14-658 UPA UC Ph3 Peds NCT05782907
- M14-671 - Crohn s Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn s Disease No ClinicalTrials.gov identifier reported
- M14-671 Rinvoq Ph 3 CD Pediatric Study NCT06332534
- M14-675 NCT03682705
- M14-675 NCT03653026